Concepedia

Author

Sourav Pal

Indian Institute of Chemical BiologyORCID

Also Known As

Dr. Sourav Pal, Pal, Sohom, Pal, Sourav, S Pal, S. P. Pal, S. Pal, Santu Pal, Sourav Pal

37

Publications

1K

Citations

13

H-Index

45

Concepts

All Affiliations

Indian Institute of Chemical BiologyAcademy of Scientific and Innovative ResearchNational Chemical LaboratoryIndian Association for the Cultivation of Science
SP

About

Sourav Pal is an author at Indian Institute of Chemical Biology specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

6

6

88

2

Natural Sciences

2

2

28

3

Education

1

1

90

4

Engineering

1

1

90

5

Public Health

1

1

15

Sourav Pal

×

18

Publications

996

Citations

13

H-Index

YearCitations

Local Softness and Hardness Based Reactivity Descriptors for Predicting Intra- and Intermolecular Reactivity Sequences: Carbonyl Compounds

Ram Kinkar Roy, S. Krishnamurti, Paul Geerlings,

The Journal of Physical Chemistry A

1998

412

Ligand-based Pharmacophore Modeling, Virtual Screening and Molecular Docking Studies for Discovery of Potential Topoisomerase I Inhibitors

Sourav Pal, Vinay Kumar, Biswajit Kundu,

Computational and Structural Biotechnology Journal

2019

186

Principle of maximum hardness: an accurate ab initio study

Sourav Pal, Nayana Vaval, Ramkinkar Roy

The Journal of Physical Chemistry

1993

90

Discovery and Mechanistic Study of Tailor-Made Quinoline Derivatives as Topoisomerase 1 Poison with Potent Anticancer Activity

Biswajit Kundu, Subhendu Das, Srijita Paul Chowdhuri,

Journal of Medicinal Chemistry

2019

69

Intermolecular Reactivity Trends Using the Concept of Group Softness

Saïlaja Krishnamurty, Sourav Pal

The Journal of Physical Chemistry A

2000

48

Systematic Optimization of Potent and Orally Bioavailable Purine Scaffold as a Dual Inhibitor of Toll-Like Receptors 7 and 9

Biswajit Kundu, Deblina Raychaudhuri, Ayan Mukherjee,

Journal of Medicinal Chemistry

2021

23

Activity-guided development of potent and selective toll-like receptor 9 antagonists

Barnali Paul, Oindrila Rahaman, Swarnali Roy,

European Journal of Medicinal Chemistry

2018

18

Exploring the Structural Attributes of Yoda1 for the Development of New-Generation Piezo1 Agonist Yaddle1 as a Vaccine Adjuvant Targeting Optimal T Cell Activation

Sunny Goon, Chinky Shiu Chen Liu, Uddipta Ghosh Dastidar,

Journal of Medicinal Chemistry

2024

18

Helical folding in heterogeneous foldamers without inter-residual backbone hydrogen-bonding

G. Priya, Amol S. Kotmale, Rupesh L. Gawade,

Chemical Communications

2012

15

Emergence of multiple variants of SARS-CoV-2 with signature structural changes

Debaleena Bhowmik, Sourav Pal, Abhishake Lahiri,

2020

15

Page 1